Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

被引：0
|
作者：
Yoshiya Horimoto
Yumiko Ishizuka
Yuko Ueki
Toru Higuchi
Atsushi Arakawa
Mitsue Saito
机构：
[1] Juntendo University School of Medicine,Department of Breast Oncology
[2] Juntendo University School of Medicine,Department of Human Pathology
[3] Japanese Red Cross Saitama Hospital,Department of Breast Oncology
来源：
BMC Cancer | / 22卷
关键词：
Breast cancer; HER2; Immunohistochemistry; hybridization; Trastuzumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
    Horimoto, Yoshiya
    Ishizuka, Yumiko
    Ueki, Yuko
    Higuchi, Toru
    Arakawa, Atsushi
    Saito, Mitsue
    [J]. BMC CANCER, 2022, 22 (01)
  • [2] HER2 status in breast cancer patients: A comparison between borderline positive HER2 and strongly positive HER2 tumors
    Huszno, J.
    Nowara, E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S137 - S137
  • [3] HER2Δ16 expression in HER2-positive breast cancer
    De Yao, Jocelyn Torres
    Sun, Danyu
    Galehouse, Donna
    Shorten, Scott
    Haller, Nairmeen
    Rehmus, Esther Hoogland
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] HER2Δ16 expression in HER2-positive breast cancer
    De Yao, Jocelyn Torres
    Sun, Danyu
    Galehouse, Donna
    Shorten, Scott
    Haller, Nairmeen Awad
    Rehmus, Esther Hoogland
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [5] HER2 mutation status in Japanese HER2-positive breast cancer patients
    Endo, Yumi
    Dong, Yu
    Kondo, Naoto
    Yoshimoto, Nobuyasu
    Asano, Tomoko
    Hato, Yukari
    Nishimoto, Mayumi
    Kato, Hiroyuki
    Takahashi, Satoru
    Nakanishi, Ryoichi
    Toyama, Tatsuya
    [J]. BREAST CANCER, 2016, 23 (06) : 902 - 907
  • [6] HER2 mutation status in Japanese HER2-positive breast cancer patients
    Yumi Endo
    Yu Dong
    Naoto Kondo
    Nobuyasu Yoshimoto
    Tomoko Asano
    Yukari Hato
    Mayumi Nishimoto
    Hiroyuki Kato
    Satoru Takahashi
    Ryoichi Nakanishi
    Tatsuya Toyama
    [J]. Breast Cancer, 2016, 23 : 902 - 907
  • [7] HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
    Morsberger, Laura
    Pallavajjala, Aparna
    Long, Patty
    Hardy, Melanie
    Park, Rebecca
    Parish, Rebecca
    Nozari, Azin
    Zou, Ying S.
    [J]. CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [8] HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
    Laura Morsberger
    Aparna Pallavajjala
    Patty Long
    Melanie Hardy
    Rebecca Park
    Rebecca Parish
    Azin Nozari
    Ying S. Zou
    [J]. Cancer Cell International, 22
  • [9] Evaluating HER2 amplification and overexpression in breast cancer
    Bartlett, JMS
    Going, JJ
    Mallon, EA
    Watters, AD
    Reeves, JR
    Stanton, P
    Richmond, J
    Donald, B
    Ferrier, R
    Cooke, TG
    [J]. JOURNAL OF PATHOLOGY, 2001, 195 (04): : 422 - 428
  • [10] High HER2 gene amplification and clinical outcomes in localized HER2-positive breast cancer
    Reynolds, K. L.
    Sasmit, S.
    Moy, B.
    Elena, B.
    Amy, C.
    Atul, B.
    Aditya, B.
    [J]. CANCER RESEARCH, 2013, 73
12345